nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Tiagabine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Tiagabine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Tiagabine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Tiagabine—Shock—Lisinopril—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Tiagabine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Tiagabine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Tiagabine—Tachycardia—Lisinopril—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Tiagabine—Abdominal pain—Azathioprine—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Tiagabine—Body temperature increased—Azathioprine—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Tiagabine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Tiagabine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Tiagabine—Diarrhoea—Captopril—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Tiagabine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Tiagabine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Tiagabine—Irritability—Methotrexate—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Tiagabine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Tiagabine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Tiagabine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Tiagabine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Tiagabine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Tiagabine—Mood swings—Methotrexate—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Tiagabine—Nausea—Mometasone—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Tiagabine—Anorexia—Lisinopril—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Tiagabine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Tiagabine—Weight increased—Prednisone—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Tiagabine—Ataxia—Methotrexate—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Tiagabine—Pain—Mycophenolic acid—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Tiagabine—Constipation—Mycophenolic acid—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Tiagabine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Tiagabine—Weight decreased—Prednisone—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Tiagabine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Tiagabine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Tiagabine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Tiagabine—Hypotension—Lisinopril—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Tiagabine—Dizziness—Captopril—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Tiagabine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Tiagabine—Depression—Prednisone—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Tiagabine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Tiagabine—Urticaria—Leflunomide—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Tiagabine—Abdominal pain—Leflunomide—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Tiagabine—Body temperature increased—Leflunomide—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Tiagabine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Tiagabine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Tiagabine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Tiagabine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Tiagabine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Tiagabine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Tiagabine—Myocardial infarction—Prednisone—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Tiagabine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Tiagabine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Tiagabine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Tiagabine—Insomnia—Lisinopril—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Tiagabine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Tiagabine—Paraesthesia—Lisinopril—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Tiagabine—Vomiting—Captopril—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Tiagabine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Tiagabine—Dyspnoea—Lisinopril—systemic scleroderma	0.00043	0.00043	CcSEcCtD
Tiagabine—Rash—Captopril—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Tiagabine—Dermatitis—Captopril—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Tiagabine—Somnolence—Lisinopril—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Tiagabine—Headache—Captopril—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Tiagabine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Tiagabine—Dyspepsia—Lisinopril—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Tiagabine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Tiagabine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Tiagabine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Tiagabine—Asthma—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Tiagabine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Tiagabine—Decreased appetite—Lisinopril—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Tiagabine—Fatigue—Lisinopril—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Tiagabine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Tiagabine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Tiagabine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Tiagabine—Constipation—Lisinopril—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Tiagabine—Pain—Lisinopril—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Tiagabine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Tiagabine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Tiagabine—Diarrhoea—Azathioprine—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Tiagabine—Haemoglobin—Prednisone—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Tiagabine—Nausea—Captopril—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Tiagabine—Haemorrhage—Prednisone—systemic scleroderma	0.000403	0.000403	CcSEcCtD
Tiagabine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Tiagabine—Asthenia—Leflunomide—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Tiagabine—Hallucination—Prednisone—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Tiagabine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Tiagabine—Pruritus—Leflunomide—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Tiagabine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000395	0.000395	CcSEcCtD
Tiagabine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Tiagabine—Dysuria—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Tiagabine—Dizziness—Azathioprine—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Tiagabine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000387	0.000387	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Tiagabine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Tiagabine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Tiagabine—Diarrhoea—Leflunomide—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Tiagabine—Urticaria—Lisinopril—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Tiagabine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Tiagabine—Body temperature increased—Lisinopril—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Tiagabine—Abdominal pain—Lisinopril—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Tiagabine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Tiagabine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Tiagabine—Vomiting—Azathioprine—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Tiagabine—Pneumonia—Methotrexate—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Tiagabine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000376	0.000376	CcSEcCtD
Tiagabine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Tiagabine—Rash—Azathioprine—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Tiagabine—Dermatitis—Azathioprine—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Tiagabine—Depression—Methotrexate—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Tiagabine—Headache—Azathioprine—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Tiagabine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Tiagabine—Dizziness—Leflunomide—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Tiagabine—Renal failure—Methotrexate—systemic scleroderma	0.000369	0.000369	CcSEcCtD
Tiagabine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Tiagabine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Tiagabine—Stomatitis—Methotrexate—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Tiagabine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Tiagabine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Tiagabine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Tiagabine—Sweating—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Tiagabine—Haematuria—Methotrexate—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Tiagabine—Vomiting—Leflunomide—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Tiagabine—Alopecia—Prednisone—systemic scleroderma	0.000356	0.000356	CcSEcCtD
Tiagabine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000355	0.000355	CcSEcCtD
Tiagabine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Tiagabine—Epistaxis—Methotrexate—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Tiagabine—Rash—Leflunomide—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Tiagabine—Dermatitis—Leflunomide—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Tiagabine—Nausea—Azathioprine—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Tiagabine—Headache—Leflunomide—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Tiagabine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Tiagabine—Asthenia—Lisinopril—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Tiagabine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000345	CcSEcCtD
Tiagabine—Pruritus—Lisinopril—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Tiagabine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00034	0.00034	CcSEcCtD
Tiagabine—Haemoglobin—Methotrexate—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Tiagabine—Rash—Mycophenolic acid—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Tiagabine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Tiagabine—Haemorrhage—Methotrexate—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Tiagabine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Tiagabine—Headache—Mycophenolic acid—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Tiagabine—Pharyngitis—Methotrexate—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Tiagabine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Tiagabine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Tiagabine—Nausea—Leflunomide—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Tiagabine—Diarrhoea—Lisinopril—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Tiagabine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Tiagabine—Visual impairment—Methotrexate—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Tiagabine—Anaemia—Prednisone—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Tiagabine—Agitation—Prednisone—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Tiagabine—Dizziness—Lisinopril—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Tiagabine—Nausea—Mycophenolic acid—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Tiagabine—Malaise—Prednisone—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Tiagabine—Vertigo—Prednisone—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Tiagabine—Syncope—Prednisone—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Tiagabine—Tinnitus—Methotrexate—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Tiagabine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Tiagabine—Loss of consciousness—Prednisone—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Tiagabine—Vomiting—Lisinopril—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Tiagabine—Rash—Lisinopril—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Tiagabine—Dermatitis—Lisinopril—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Tiagabine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Tiagabine—Hypertension—Prednisone—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Tiagabine—Chills—Methotrexate—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Tiagabine—Headache—Lisinopril—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Tiagabine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Tiagabine—Arthralgia—Prednisone—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Tiagabine—Myalgia—Prednisone—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Tiagabine—Anxiety—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Tiagabine—Alopecia—Methotrexate—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Tiagabine—Discomfort—Prednisone—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Tiagabine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Tiagabine—Dysgeusia—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Tiagabine—Nausea—Lisinopril—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Tiagabine—Oedema—Prednisone—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Tiagabine—Infection—Prednisone—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Tiagabine—Back pain—Methotrexate—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Tiagabine—Shock—Prednisone—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Tiagabine—Tachycardia—Prednisone—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Tiagabine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Tiagabine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Tiagabine—Anorexia—Prednisone—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Tiagabine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Tiagabine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Tiagabine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Tiagabine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Tiagabine—Malaise—Methotrexate—systemic scleroderma	0.000264	0.000264	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Tiagabine—Insomnia—Prednisone—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Tiagabine—Paraesthesia—Prednisone—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Tiagabine—Cough—Methotrexate—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Tiagabine—Dyspepsia—Prednisone—systemic scleroderma	0.000252	0.000252	CcSEcCtD
Tiagabine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Tiagabine—Decreased appetite—Prednisone—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Tiagabine—Fatigue—Prednisone—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Tiagabine—Constipation—Prednisone—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Tiagabine—Confusional state—Methotrexate—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Tiagabine—Infection—Methotrexate—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Tiagabine—Feeling abnormal—Prednisone—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Tiagabine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Tiagabine—Urticaria—Prednisone—systemic scleroderma	0.000227	0.000227	CcSEcCtD
Tiagabine—Abdominal pain—Prednisone—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Tiagabine—Body temperature increased—Prednisone—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000218	0.000218	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Tiagabine—Hypersensitivity—Prednisone—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Tiagabine—Dyspepsia—Methotrexate—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Tiagabine—Decreased appetite—Methotrexate—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Tiagabine—Fatigue—Methotrexate—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Tiagabine—Asthenia—Prednisone—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Tiagabine—Pain—Methotrexate—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Tiagabine—Pruritus—Prednisone—systemic scleroderma	0.000202	0.000202	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Tiagabine—Diarrhoea—Prednisone—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Tiagabine—Dizziness—Prednisone—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Tiagabine—Vomiting—Prednisone—systemic scleroderma	0.000182	0.000182	CcSEcCtD
Tiagabine—Rash—Prednisone—systemic scleroderma	0.00018	0.00018	CcSEcCtD
Tiagabine—Dermatitis—Prednisone—systemic scleroderma	0.00018	0.00018	CcSEcCtD
Tiagabine—Headache—Prednisone—systemic scleroderma	0.000179	0.000179	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Tiagabine—Nausea—Prednisone—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—systemic scleroderma	0.000152	0.000152	CcSEcCtD
Tiagabine—Rash—Methotrexate—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Tiagabine—Headache—Methotrexate—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Tiagabine—Nausea—Methotrexate—systemic scleroderma	0.000142	0.000142	CcSEcCtD
